EGFR and non-small cell lung carcinoma: Human epidermal growth factor receptor 3 (HER3) is overexpressed in many solid tumors and is particularly upregulated in EGFR-mutant NSCLC as a compensatory mechanism leading to resistance to TKIs [79].